Stay updated on GEMINI 2 Tolebrutinib in RMS Clinical Trial
Sign up to get notified when there's something new on the GEMINI 2 Tolebrutinib in RMS Clinical Trial page.

Latest updates to the GEMINI 2 Tolebrutinib in RMS Clinical Trial page
- Check5 days agoNo Change Detected
- Check13 days agoChange DetectedThe page's revision label was updated from v3.6.2 to v3.6.3, signaling a newly released iteration of the page's content. This update appears to be a technical revision rather than a change in user-facing information.SummaryDifference0.0%

- Check20 days agoChange DetectedThe page now shows Revision: v3.6.2, replacing the previous v3.6.0 label. This reflects a minor update or maintenance release of the page rather than a change to study details or content.SummaryDifference0.0%

- Check34 days agoChange DetectedThe page now signals that recruitment is closed to new participants and adds How to Read a Study Record, Common Questions, and How to Join a Study for user guidance. The Interventions header formatting changed from 'Intervention / Treatment' to 'Intervention/Treatment', and the revision indicator was updated to Revision: v3.6.0.SummaryDifference0.2%

- Check41 days agoChange DetectedA new revision tag 'Revision: v3.5.5' has been added, and the previous 'Revision: v3.5.4' has been removed. This signals a refreshed release of the page content.SummaryDifference0.0%

- Check62 days agoChange DetectedRevision tag updated from v3.5.3 to v3.5.4, indicating a software/build update for the page. This change does not alter the study content or public-facing information.SummaryDifference0.0%

- Check84 days agoChange DetectedThe study’s location listing for “Gūrgaon, India” was normalized to “Gurgaon, India” for two entries, likely correcting diacritic formatting. The page also reflects an update to the site/page “Revision” version.SummaryDifference0.1%

Stay in the know with updates to GEMINI 2 Tolebrutinib in RMS Clinical Trial
Enter your email address, and we'll notify you when there's something new on the GEMINI 2 Tolebrutinib in RMS Clinical Trial page.